Lightpoint Medical is a technology company that is a pioneer in developing and marketing precision-guided cancer surgery. Surgeons aren't able to see if the cancerous tissue has been removed in its entirety or not during a surgery. To better this situation, the company has developed an imaging technology based on PET radiopharmaceuticals, more precisely, Cerenkov Luminescence Imaging (CLI), which helps surgeons to detect cancer in a real-time during surgery. The company's first product has received marketing authorisation, i.e., the CE (European Conformity) Mark. A second product, a laparoscopic device for prostate cancer is in development. A non-clinical device has also been released. For its efforts, Lightpoint Medical won the 'Best in Show' Award at the 2014 MedTech Investing Europe Conference. The company aims to utilise the investment to scale its business.
days to go:
Expired
investment:
Withheld
The Landsite is the UK's first online property portal that connects various entities within the property industry such as developers, legal services, insurance advisors and architects, to one another, simplifying the process of finding and buying a property. By registering with The Landsite, a business/professional can list their business as operating in a specific region of the country and appear against all property searches that take place in that same region. The user then needs to put in their postcode or address and can then access properties within that region, as well as, seek available professional guidance to zero in upon a potential purchase. The platform also has an insights page that aims to become a recruitment, training and educational hub for the property industry. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
Withheld
DotFrames is pioneering an AI, VR, and AR-powered e-commerce platform for immersive 3D experiences. Their focus is on media and entertainment, creating hyper-real galleries for art and collectibles. They aim to develop a next-gen Shopify platform-as-a-service, enabling clients to showcase and sell various products in immersive environments. The investment will fuel platform development. DotFrames merges technology and artistry, reshaping art appreciation.
days to go:
Expired
investment:
£100,000
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go:
Expired
investment:
Withheld
Orthogem is a UK based manufacturer of synthetic bone grafts. Synthetic bone grafts are substitutes for human bone grafts and are designed to replace bone that has been lost. Orthogem have recently started to produce their product in a putty form in order to keep up with the changes in the market.
days to go:
Expired
investment:
£722,784
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go:
Expired
investment:
£50,000
